This program features topics relevant to the multidisciplinary team approach to caring for patients receiving CAR T-cell therapies and their relatives.
This program features topics relevant to the multidisciplinary team approach to caring for patients receiving CAR T-cell therapies and their relatives.
The CAR (Chimeric Antigen Receptor) T-cell therapies: a resource for healthcare professionals learning program was made possible by an educational grant from Celgene / Bristol Myers Squibb Company, Janssen-Cilag AG, Novartis and Kite Gilead.
Dieses Projekt wurde aus Mitteln des Forschungs- und Innovationsprogramms Horizont 2020 der Europäischen Union unter der Finanzhilfevereinbarung Nr. 965241 finanziert.
© Copyright 2020-2025 EuroGCT and contributing authors